Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 937 trades; $2B in total
Open-market sales: 1,050 trades; $2.3B in total
Insiders filing: 472 insiders; Last 7 days
Companies with several buyers: 28; Last 7 days

Rain Enhancement Technologies Holdco RAIN

		Trade type
CEO	Rain Enhancement Technologies HoldcoRAIN	Open-market buy	25/05/20–25/05/22	05/22	42,514 sh3 trades	$2.37avg.	$100,949.22	+7.1%
Director	Rain Enhancement Technologies HoldcoRAIN	Open-market sale	25/09/09–25/09/12	25/09/17	7,317 sh4 trades	$5.63avg.	$41,215.59	−41.7%
Paul T. Dacier10% Owner	Rain Enhancement Technologies HoldcoRAIN	Open-market buy	25/02/06	25/02/10	13,173 sh	$11.39	$150,040.47	No record
Paul T. Dacier10% Owner	Rain Enhancement Technologies HoldcoRAIN	Open-market buy	24/12/31	24/12/31	8,782 sh	$11.39	$100,026.98	+0.5%
10% Owner	Rain Oncology	Open-market sale	23/12/14–23/12/18	23/12/18	173,973 sh3 trades	$1.20avg.	$209,412.98	−4.3%
10% Owner	Rain Oncology	Open-market sale	23/12/14–23/12/18	23/12/18	173,973 sh3 trades	$1.20avg.	$209,412.98	−4.3%
10% Owner	Rain Oncology	Open-market sale	23/12/14–23/12/18	23/12/18	173,973 sh3 trades	$1.20avg.	$209,412.98	−4.3%
10% Owner	Rain Oncology	Open-market buy	23/10/11–23/10/13	23/10/13	284,145 sh5 trades	$0.98avg.	$279,030.29	+7.6%
10% Owner	Rain Oncology	Open-market buy	23/10/11–23/10/13	23/10/13	284,145 sh5 trades	$0.98avg.	$279,030.29	+7.6%
10% Owner	Rain Oncology	Open-market buy	23/10/11–23/10/13	23/10/13	284,145 sh5 trades	$0.98avg.	$279,030.29	+7.6%
10% Owner	Rain Oncology	Open-market buy	23/05/30–23/06/01	23/06/01	1,088,273 sh9 trades	$1.06avg.	$1,158,763.96	+41.0%
10% Owner	Rain Oncology	Open-market buy	23/05/30–23/06/01	23/06/01	1,088,273 sh9 trades	$1.06avg.	$1,158,763.96	+41.0%
10% Owner	Rain Oncology	Open-market buy	23/05/30–23/06/01	23/06/01	1,088,273 sh9 trades	$1.06avg.	$1,158,763.96	+41.0%
Joseph LewisOther	Rain Oncology	Open-market sale	23/05/22	23/05/24	995,000 sh	$1.25	$1,243,750	−46.3%
Boxer Asset ManagementOther	Rain Oncology	Open-market sale	23/05/22	23/05/24	995,000 sh	$1.25	$1,243,750	−46.3%
Boxer CapitalDirector	Rain Oncology	Open-market sale	23/05/22	23/05/24	995,000 sh	$1.25	$1,243,750	−46.3%
Aaron I. Davis	Rain Oncology	Open-market sale	23/05/22	23/05/24	995,000 sh	$1.25	$1,243,750	−46.3%